Mometasona Sandoz (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasona Sandoz, is a potent corticosteroid presented as a nasal spray for local nasal administration. It reduces inflammation of the nasal mucosa and provides relief from symptoms of allergic rhinitis, such as sneezing, itching, and nasal congestion, in both adult and pediatric patients when prescribed by a qualified clinician. The formulation is designed for once‑daily use and is approved for use in the European Union market.

GNH USA supplies Mometasona Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasona Sandoz, a nasal corticosteroid, is indicated for inflammatory conditions of the nasal passages.

Allergic rhinitis (perennial): reduces nasal inflammation and alleviates sneezing, itching, and rhinorrhea. Seasonal allergic rhinitis: controls seasonal nasal symptoms and improves patient comfort. Nasal congestion due to allergic inflammation: decreases swelling of nasal mucosa, enhancing airflow.

Mometasona Sandoz may cause local and systemic adverse reactions, which are categorized by frequency.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleeds) - Headache - Altered taste - Dryness of nasal passages

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or cataract formation - Adrenal suppression with prolonged high‑dose use

When prescribing Mometasona Sandoz, clinicians should consider the following precautions to ensure safe use.

Duration of therapy: limit use to the shortest effective period to minimize systemic exposure. Nasal bleeding: monitor patients for epistaxis and advise gentle nasal care. Glaucoma or cataract risk: use with caution in patients with a history of ocular hypertension. Recent nasal surgery or trauma: avoid or defer use until healing is complete. Hypersensitivity: contraindicated in individuals with known allergy to mometasone furoate or formulation excipients. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mometasona Sandoz can interact with other medicines, affecting its safety or efficacy.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may increase systemic corticosteroid levels. - Concurrent use of other intranasal corticosteroids: raises risk of systemic glucocorticoid effects.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance sedative effects in sensitive individuals. - Immunosuppressants (e.g., azathioprine): combined use could further suppress immune response. - Nasal decongestant sprays: prolonged combined use may increase local irritation.